Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Institute of Medicine. 2010. Rare Diseases and Orphan Products: Accelerating Research and Development. Washington, DC: The National Academies Press. https://doi.org/10.17226/12953.
|2 Profile of Rare Diseases||41-72|
|3 Regulatory Framework for Drugs for Rare Diseases||73-110|
|4 Discovery Research for Rare Diseases and Orphan Product Development||111-146|
|5 Development of New Therapeutic Drugs and Biologics for Rare Diseases||147-178|
|6 Coverage and Reimbursement: Incentives and Disincentives for Product Development||179-204|
|7 Medical Devices: Research and Development for Rare Diseases||205-240|
|8 Toward an Integrated Approach to Accelerating Research and Product Development for Rare Diseases||241-248|
|Appendix A: Study Activities||283-290|
|Appendix B: Innovation and the Orphan Drug Act, 1983-2009: Regulatory and Clinical Characteristics of Approved Orphan Drugs||291-308|
|Appendix C: Medicare Part D Coverage and Reimbursement of Orphan Drugs||309-344|
|Appendix D: Glossary, Abbreviations, and Public Laws||345-364|
|Appendix E: Rare Diseases Clinical Research Network||365-370|
|Appendix F: Advocacy Group Approaches to Accelerating Research and Product Development: Illustrative Examples||371-386|
|Appendix G: Committee and Staff Biographies||387-394|
The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, pleaseclick here to view more information.